Skip to main content
. 2023 Feb 1;21:15. doi: 10.1186/s12958-023-01064-y

Table 1.

Basic clinical characteristics of Control, PCOM, and PCOS groups

Control ( n  = 9316) PCOM ( n  = 2879) PCOS ( n  = 3775) P value
Age (y) 29.19 ± 2.982,3 28.06 ± 3.0791 28.05 ± 3.0731  < 0.001*
BMI (kg/m2) 22.36 ± 3.062,3 22.85 ± 3.311,3 24.34 ± 3.581,2  < 0.001*
T (ng/ml) 0.24 ± 0.102,3 0.28 ± 0.101,3 1.18 ± 6.191,2  < 0.001*
AMH (ng/ml) 2.92 ± 1.552,3 5.27 ± 2.551,3 7.55 ± 4.001,2  < 0.001*
LH/FSH 0.77 ± 0.402,3 0.98 ± 0.551,3 1.68 ± 1.121,2  < 0.001*

Data were presented as the mean ± SD. PCOS Polycystic ovary syndrome, PCOM Polycystic ovary morphology, BMI Body mass index, T Testosterone, AMH Anti-Müllerian hormone, FSH Follicle stimulating hormone, LH Luteinizing hormone

*P: significant difference among the groups. 1P: significant difference from the control group; 2P: significant difference from the PCOM group; 3P: significant difference from the PCOS group